| Product Name | MF | CAS | Details |
|---|
| Thalidomide | C13H10N2O4 | 50-35-1 | Details |
| Viglietin impurity D (degradation of amide impurities) | Details |
| BENZP-DINITRIDE-THIO-KETONE | C15H11ClN2S | 4547-02-8 | Details |
| 4-Amino-3,5-dichloroacetophenone | C8H7Cl2NO | 37148-48-4 | Details |
| Corticotropin | C207H308N56O58S | 9002-60-2 | Details |
| 4-Amino-3,5-dichlorophenacylbromide | C8H6BrCl2NO | 37148-47-3 | Details |
| 4-Hydrazinobenzene-1-sulfonamide hydrochloride | C6H10ClN3O2S | 17852-52-7 | Details |
| 6-Fluoro-1H-indole-4-carboxylic acid methyl ester | C10H8FNO2 | 1082040-43-4 | Details |
| N-De(4-sulfonaMidophenyl)-N'-(4-sulfonaMidophenyl) Celecoxib;4-[3-(4-Methylphenyl)-5-(trifluoroMethyl)-1H-pyrazol-1-yl]benzenesulfonaMide | C17H14F3N3O2S | 331943-04-5 | Details |
| PARECOXIB SODIUM | C19H19N2NaO4S | 198470-85-8 | Details |
| 4-DesMethyl-3-Methyl Celecoxib;4-[5-(3-Methylphenyl)-3-trifluoroMethyl-1H-pyrazol-1-yl]benzenesulfonamide | C17H14F3N3O2S | 170570-01-1 | Details |
| Vildagliptin IMPURITY B | C24H33N5O3 | 1036959-23-5 | Details |
| Tetraethylammonium hexafluorophosphate | C8H20F6NP | 429-07-2 | Details |
| TRANS-CYCLOBUTANE-1,2-DICARBOXYLIC ACID | C6H8O4 | 1124-13-6 | Details |
| CIS-CYCLOBUTANE-1,2-DICARBOXYLIC ACID | C6H8O4 | 1461-94-5 | Details |
| viminol | C21H31ClN2O | 21363-18-8 | Details |
| Dimethyl2,2'-Dibromoadipate | C8H12Br2O4 | 868-72-4 | Details |
| 1-Cyclobutene-1,2-dicarboxylic acid | C6H6O4 | 16508-05-7 | Details |
| 8-fluoro-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one | C11H9FN2O | 1408282-26-7 | Details |
| Telbivudine | C10H14N2O5 | 3424-98-4 | Details |
| VALDECOXIB | C16H14N2O3S | 181695-72-7 | Details |
| 4-ALLYLOXY-2-HYDROXYBENZOPHENONE | C16H14O3 | 2549-87-3 | Details |
| TETRAPROPYLAMMONIUM HEXAFLUOROPHOSPHATE | C12H28F6NP | 12110-21-3 | Details |
| brexpiprazole | C25H27N3O2S | 913611-97-9 | Details |
| 2'-BENZOYL-2,4'-DICHLOROACETANILIDE | C15H11Cl2NO2 | 4016-85-7 | Details |
| ADINAZOLAM | C19H18ClN5 | 37115-32-5 | Details |
| Celecoxib ortho-imparting impurities | C17H14F3N3O2S | Details |
| N-HEXADECYLTRIMETHYLAMMONIUM HEXAFLUOROPHOSPHATE | C19H42F6NP | 101079-29-2 | Details |
| Viglietin impurity A (R-configuration optical isomer) | Details |
| TETRAMETHYLAMMONIUM HEXAFLUOROPHOSPHATE | C4H12F6NP | 558-32-7 | Details |
| Tetrabutylammonium hexafluorophosphate | C16H36F6NP | 3109-63-5 | Details |
| Celecoxib | C17H14F3N3O2S | 169590-42-5 | Details |
| Cyclobutane-1,2-dicarboxylic anhydride | C6H6O3 | 4462-96-8 | Details |
| BENZYLTRIMETHYLAMMONIUM HEXAFLUOROPHOSPHATE | C10H16F6NP | 6427-70-9 | Details |
| 1-(1-(2-fluorobenzyl)-1H-pyrrol-2-yl)-2-(di-sec-butylamino)ethanol | C21H31FN2O | 63880-43-3 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||